Table 2.
Clinical characteristics and courses of patients treated with revascularization therapy including IVT, MT, or bypass surgery
| No. | Age | Sex | OTD | Stroke subtype | ICT and MCA | Initial NIHSS | Initial therapy (IVT time from onset | REND time from) onset | Rescue revascularization | mRS at discharge |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 48 | M | 280 min | LAD | Not patent | 5 | AT | Several days | None | 4 |
| 2 | 87 | F | 90 min | CES | Not patent | 5 | IVT (117 min) | 165 min | None | 6 |
| 3 | 45 | M | 50 min | Arterial dissection | Patent | 2 | AT | 250 min | None | 2 |
| 4 | 85 | M | 711 min | LAD | Patent | 5 | AT | Several days | None | 5 |
| 5 | 88 | F | 810 min | LAD | Not patent | 3 | AT | Several days | None | 5 |
| 6 | 84 | M | 80 min | LAD | Patent | 5 | AT | 1 day | None | 5 |
| 7 | 75 | M | 169 min | Aortogenic emboli | Patent | 4 | IVT (200 min) | 545 min | MT | 5 |
| 8 | 79 | M | 420 min | LAD | Patent | 5 | AT | 3 days | None | 4 |
| 9 | 61 | F | 60 min | LAD | Not patent | 0 | AT | 215 min | None | 5 |
| 10 | 65 | F | 980 min | LAD | Not patent | 4 | AT | 1 day | Bypass surgery | 5 |
| 11 | 85 | F | 100 min | CES | Patent | 4 | Not yet initiated | 110 min | IVT + MT | 0 |
| 12 | 74 | M | 270 min | LAD | Patent | 1 | AT | 1 day | Bypass surgery | 2 |
| 13 | 75 | M | 48 min | CES | Patent | 5 | IVT (135 min) | 435 min | MT | 5 |
IVT, intravenous thrombolysis; MT, mechanical thrombectomy; OTD, onset-to-door time; ICT, internal carotid artery terminus; MCA, middle cerebral artery; CES, cardioembolic stroke; LAD, large artery disease; NIHSS, National Institutes of Health Stroke Scale; AT, antithrombotic therapy; REND, recurrence of stroke or early neurological deterioration with increment in NIHSS score ≥1 during hospital stay; mRS, modified Rankin Scale.